Lennar director Jeffrey Sonnenfeld receives 21 stock units

The DSUs are tied to deferred director fees and an annual grant, and do not convert into Class A shares until board service ends.

Rhea-AI Filing Summary

Lennar Corporation director Jeffrey Sonnenfeld received 21 deferred stock units (DSUs) on October 7, 2026, issued in respect of deferred quarterly cash director fees and an unvested annual DSU grant, including dividend equivalents. The referenced $76.13 per share was the common stock closing price on the dividend record date. The Director’s Fee DSUs are fully vested; the Annual Grant DSUs vest with the related annual grant, and neither converts into Class A Common Stock until Sonnenfeld leaves the board. Reported post-transaction balances were 28,209 shares of Class A Common Stock and 591 shares of Class B Common Stock.

Insider Trade Summary

Grant/Award: 21 shares

Grant/Award 2 txns

Insider SONNENFELD JEFFREY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Class A Common Stock F1, F2	21	$76.13	$2K
holding	Class B Common Stock	--	--	--

Holdings After Transaction: Class A Common Stock — 28,209 shares (Direct); Class B Common Stock — 591 shares (Direct)

Footnotes (2)

1. F1. Represents deferred stock units ("DSUs") issued in respect of the Reporting Person's deferred quarterly cash director's fee (the "Director's Fee DSUs") and DSUs issued in respect of the Reporting Person's unvested annual DSU grant (the "Annual Grant DSUs") (including dividend equivalents in respect of both the Director's Fee DSUs and Annual Grant DSUs), each as a result of the dividend on the Issuer's common stock with a record date of October 7, 2026, in accordance with the Issuer's outside directors' compensation program. The Director's Fee DSUs are fully vested and the Annual Grant DSUs will vest at the same time as the annual DSU grant to which they relate, but neither will convert into shares of Class A Common Stock until the Reporting Person ceases to be a member of the Board of Directors. Fractional amounts have been rounded down to the nearest whole number.
2. F2. Represents the closing price per share of Issuer's common stock as of the record date.

Key Figures

Deferred stock units: 21 DSUs Common stock closing price: $76.13 per share Class A Common Stock: 28,209 shares +1 more

4 metrics

Deferred stock units 21 DSUs Issued in respect of deferred quarterly cash director fees and an unvested annual DSU grant, including dividend equivalents

Common stock closing price $76.13 per share Closing price on the October 7, 2026 record date

Class A Common Stock 28,209 shares Reported balance following the transaction

Class B Common Stock 591 shares Reported direct holding on October 7, 2026

Key Terms

deferred stock units, Director's Fee DSUs, Annual Grant DSUs, dividend equivalents

4 terms

deferred stock units financial

"Represents deferred stock units ("DSUs") issued in respect of"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

Director's Fee DSUs financial

"The Director's Fee DSUs are fully vested"

Annual Grant DSUs financial

"the Annual Grant DSUs will vest at the same time"

dividend equivalents financial

"including dividend equivalents in respect of both the Director's Fee DSUs and Annual Grant DSUs"

Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many DSUs did LEN director Jeffrey Sonnenfeld receive?

Jeffrey Sonnenfeld received 21 DSUs on October 7, 2026. They were issued in respect of deferred quarterly cash director fees and an unvested annual DSU grant, including dividend equivalents, following the common stock dividend record date.

When do Jeffrey Sonnenfeld's LEN DSUs convert into shares?

The Director’s Fee DSUs are fully vested, and the Annual Grant DSUs vest at the same time as the annual DSU grant to which they relate. Neither converts into Class A Common Stock until Sonnenfeld ceases to be a member of the board.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/08/2026 - 06:47 PM Accepted by SEC EDGAR 10/08/2026 - 06:47 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

SONNENFELD JEFFREY

(Last) (First) (Middle)

5505 WATERFORD DISTRICT DRIVE

(Street)

MIAMI FLORIDA 33126

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LENNAR CORP /NEW/ [ LEN, LEN.B ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/07/2026		A		21(1)	A	$76.13(2)	28,209	D
Class B Common Stock								591	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents deferred stock units ("DSUs") issued in respect of the Reporting Person's deferred quarterly cash director's fee (the "Director's Fee DSUs") and DSUs issued in respect of the Reporting Person's unvested annual DSU grant (the "Annual Grant DSUs") (including dividend equivalents in respect of both the Director's Fee DSUs and Annual Grant DSUs), each as a result of the dividend on the Issuer's common stock with a record date of October 7, 2026, in accordance with the Issuer's outside directors' compensation program. The Director's Fee DSUs are fully vested and the Annual Grant DSUs will vest at the same time as the annual DSU grant to which they relate, but neither will convert into shares of Class A Common Stock until the Reporting Person ceases to be a member of the Board of Directors. Fractional amounts have been rounded down to the nearest whole number.

2. Represents the closing price per share of Issuer's common stock as of the record date.

	/s/ Mark Liberman as attorney-in-fact for Jeffrey Sonnenfeld	10/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)